Clinical trial
Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost
NCT00347841 · Innovative Medical, Industry · Completed
Key facts
| NCT number | NCT00347841 |
|---|---|
| Title | Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost |
| Official title | Efficacy of Bimatoprost 0.03% in Patients Who Are Low-Responders to Latanoprost |
| Lead sponsor | Innovative Medical, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Glaucoma |
| Intervention type | Drug |
| Interventions | Bimatoprost 0.03%, Latanoprost |
| First posted | Jul 4, 2006 |
| Last update posted | Jun 1, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: